These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 24845156)

  • 1. Inflammatory unbalance of TLR3 and TLR4 in PCI patients with or without type 2 diabetes mellitus.
    Shao L; Zhang P; Zhang Y; Ma A
    Immunol Lett; 2014 Sep; 161(1):81-8. PubMed ID: 24845156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TLR3 and TLR4 as potential clinically biomarkers of cardiovascular risk in coronary artery disease (CAD) patients.
    Shao L; Zhang P; Zhang Y; Lu Q; Ma A
    Heart Vessels; 2014 Sep; 29(5):690-8. PubMed ID: 24146036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TLR3 and TLR4 as potential clinical biomarkers for in-stent restenosis in drug-eluting stents patients.
    Liang S; Aiqun M; Jiwu L; Ping Z
    Immunol Res; 2016 Apr; 64(2):424-30. PubMed ID: 26318748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased mucosal expression of Toll-like receptor (TLR)2 and TLR4 in coeliac disease.
    Szebeni B; Veres G; Dezsofi A; Rusai K; Vannay A; Bokodi G; Vásárhelyi B; Korponay-Szabó IR; Tulassay T; Arató A
    J Pediatr Gastroenterol Nutr; 2007 Aug; 45(2):187-93. PubMed ID: 17667714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptor 2 and 4 stimulation elicits an enhanced inflammatory response in human obese patients with atherosclerosis.
    Scholtes VP; Versteeg D; de Vries JP; Hoefer IE; Schoneveld AH; Stella PR; Doevendans PA; van Keulen KJ; de Kleijn DP; Moll FL; Pasterkamp G
    Clin Sci (Lond); 2011 Sep; 121(5):205-14. PubMed ID: 21446916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Toll like receptor 4 gene expression of PBMCs in diabetes mellitus type 2 patients.
    Sepehri Z; Kiani Z; Nasiri AA; Mashhadi MA; Javadian F; Haghighi A; Kohan F; Bahari A; Sargazi A
    Cell Mol Biol (Noisy-le-grand); 2015 Jul; 61(3):92-5. PubMed ID: 26255137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptor 2, 3, and 4 expression and function in human airway smooth muscle.
    Sukkar MB; Xie S; Khorasani NM; Kon OM; Stanbridge R; Issa R; Chung KF
    J Allergy Clin Immunol; 2006 Sep; 118(3):641-8. PubMed ID: 16950283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRIF-mediated TLR3 and TLR4 signaling is negatively regulated by ADAM15.
    Ahmed S; Maratha A; Butt AQ; Shevlin E; Miggin SM
    J Immunol; 2013 Mar; 190(5):2217-28. PubMed ID: 23365087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rho proteins are negative regulators of TLR2, TLR3, and TLR4 signaling in astrocytes.
    Borysiewicz E; Fil D; Konat GW
    J Neurosci Res; 2009 May; 87(7):1565-72. PubMed ID: 19115402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher expression of Toll-like receptors 2, 3, 4, and 8 in ocular Behcet's disease.
    Liu X; Wang C; Ye Z; Kijlstra A; Yang P
    Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6012-7. PubMed ID: 23908180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TLR3/4 signaling is mediated via the NFκB-CXCR4/7 pathway in human alcoholic hepatitis and non-alcoholic steatohepatitis which formed Mallory-Denk bodies.
    Liu H; Li J; Tillman B; Morgan TR; French BA; French SW
    Exp Mol Pathol; 2014 Oct; 97(2):234-40. PubMed ID: 24997224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of TLR3, TLR4, TLR7 and TLR9 in esophageal squamous cell carcinoma.
    Sheyhidin I; Nabi G; Hasim A; Zhang RP; Ainiwaer J; Ma H; Wang H
    World J Gastroenterol; 2011 Aug; 17(32):3745-51. PubMed ID: 21990957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scaffolding adaptor protein Gab1 is required for TLR3/4- and RIG-I-mediated production of proinflammatory cytokines and type I IFN in macrophages.
    Zheng Y; An H; Yao M; Hou J; Yu Y; Feng G; Cao X
    J Immunol; 2010 Jun; 184(11):6447-56. PubMed ID: 20435932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of toll-like receptor 4 and inflammatory cytokines, interleukin-6 in particular, in islets from a mouse model of obesity and type 2 diabetes.
    Ladefoged M; Buschard K; Hansen AM
    APMIS; 2013 Jun; 121(6):531-8. PubMed ID: 23134512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of inflammatory response of astrocytes induced by TLR 3 and TLR4 ligation.
    Krasowska-Zoladek A; Banaszewska M; Kraszpulski M; Konat GW
    J Neurosci Res; 2007 Jan; 85(1):205-12. PubMed ID: 17061254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monocyte toll-like receptor 2 and 4 responses and expression following percutaneous coronary intervention: association with lesion stenosis and fractional flow reserve.
    Versteeg D; Hoefer IE; Schoneveld AH; de Kleijn DP; Busser E; Strijder C; Emons M; Stella PR; Doevendans PA; Pasterkamp G
    Heart; 2008 Jun; 94(6):770-6. PubMed ID: 17686802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presymptomatic differences in Toll-like receptor function in infants who have allergy.
    Prescott SL; Noakes P; Chow BW; Breckler L; Thornton CA; Hollams EM; Ali M; van den Biggelaar AH; Tulic MK
    J Allergy Clin Immunol; 2008 Aug; 122(2):391-9, 399.e1-5. PubMed ID: 18571707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-like receptor 4 (TLR4), but not TLR3 or TLR9, knock-out mice have neuroprotective effects against focal cerebral ischemia.
    Hyakkoku K; Hamanaka J; Tsuruma K; Shimazawa M; Tanaka H; Uematsu S; Akira S; Inagaki N; Nagai H; Hara H
    Neuroscience; 2010 Nov; 171(1):258-67. PubMed ID: 20804821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botanically-Derived Δ
    Fitzpatrick JM; Hackett B; Costelloe L; Hind W; Downer EJ
    Molecules; 2022 Mar; 27(6):. PubMed ID: 35335126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of coronary artery disease and percutaneous intervention on the cardiac metabolism of nonesterified fatty acids and insulin: Implications of diabetes mellitus.
    Jaumdally RJ; Lip GY; Patel JV; MacFadyen RJ; Varma C
    J Intern Med; 2009 Jun; 265(6):689-97. PubMed ID: 19226374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.